CClinicalTrials.gg
Not yet recruitingNCT07382245Updated Feb 2, 2026

Efficacy of Silver Diamine Fluoride Versus Nano-Silver Fluoride in Arresting Active Dentin Caries in Primary Teeth in Young Children

An interventional study of Nano-Silver Fluoride and Silver Diamine Fluoride in Early Childhood Caries (ECC) and Active Dentin Caries in Primary Molars, sponsored by October University for Modern Sciences and Arts. Not yet recruiting at 1 site in Egypt. Open to participants aged 3 Years to 5 Years. Per ClinicalTrials.gov, last updated 2026-02-02.

Sponsored by October University for Modern Sciences and Arts · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2026, 7 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
3 Years to 5 Years
Sex
All
01

Study summary

Early childhood caries is a major public health problem affecting preschool children worldwide. Silver Diamine Fluoride is a well-established non-invasive treatment for arresting caries; however, it causes black discoloration of treated lesions. Nano-Silver Fluoride has been introduced as an alternative that may arrest caries without discoloration.

This randomized clinical trial aims to compare the efficacy of Silver Diamine Fluoride and Nano-Silver Fluoride in arresting active dentin caries in primary teeth and to assess discoloration, post-operative pain, and parental satisfaction over a 12-month follow-up period.

Read the detailed description

This randomized clinical trial will be conducted on 30 children aged 3-5 years attending the outpatient clinic of Pediatric Dentistry, Faculty of Dentistry, Suez Canal University. Children with active dentin caries in primary molars will be randomly allocated into two groups: Silver Diamine Fluoride group and Nano-Silver Fluoride group.

Both materials will be applied topically without caries excavation. Clinical evaluation will be performed at baseline and at 1, 3, 6, 9, and 12 months using ICDAS criteria, visual and tactile examination, assessment of post-operative pain, discoloration through standardized photographs, and parental satisfaction questionnaires.

The primary outcome is caries arrest. Secondary outcomes include discoloration, pain, and parental satisfaction.

02

Conditions studied

  • Early Childhood Caries (ECC)
  • Active Dentin Caries in Primary Molars

Keywords

  • Early Childhood Caries
  • primary molar
  • Nano-Silver Fluoride
  • Silver Diamine Fluoride
  • SDF
03

In context

Lead sponsor

October University for Modern Sciences and Arts is the lead sponsor of 50 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Apparently healthy children.
  • Children with age ranged from 3-5 years from both genders.
  • Children who refused dental treatment with Frankl Behavior Rating Scale 1 and 2.
  • Children having molars with active dentin caries score (2,3,4) according to International Caries Detection and Assessment System- ICDAS II, detected by visual and tactile.
  • Parents/guardians accept treatment and write informed consent.

Exclusion criteria

Exclusion Criteria:

  • Children with allergy to silver from their medical history.
  • Children with ulcerative gingivitis.
  • Children with primary molars with the following criteria:
  • Symptomatic
  • Involving the pulp
  • Presence of fistula or sinus
  • Presence of gingival inflammation and Pain on percussion
  • Close to exfoliation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Arm A: Nano-Silver Fluoride

    Topical application of Nano-Silver Fluoride varnish containing silver nanoparticles, chitosan, and fluoride applied to active dentin caries lesions in primary molars. Application will be performed twice: at baseline and after 6 months, without caries excavation or restoration.

    Drug: Nano-Silver Fluoride

  • Active comparator
    Arm B: Silver Diamine Fluoride

    Topical application of 38% Silver Diamine Fluoride varnish applied to active dentin caries lesions in primary molars. Application will be performed twice: at baseline and after 6 months, without caries excavation or restoration.

    Drug: Silver Diamine Fluoride

Interventions

  • DrugNano-Silver Fluoride

    Chitosan (28,585 μg/ml), Silver (376.5 μg/ml) and Sodium fluoride (5028.3 μg/ml)

  • DrugSilver Diamine Fluoride

    38% Silver Diamine Fluoride

06

What researchers measure

Primary outcomes

  1. Caries arrest of active dentin caries

    Arrest of caries assessed clinically by hardness of dentin using blunt periodontal probe and ICDAS criteria

    Time frame: 1, 3, 6, 9 and 12 months

Secondary outcomes

  1. Discoloration of carious lesions

    Assessment of color change using standardized pre- and post-operative photographs

    Time frame: 1, 3, 6, 9 and 12 months

  2. Post-operative pain

    Presence or absence of pain assessed through parental interview

    Time frame: 1, 3, 6, 9 and 12 months

  3. Parental satisfaction

    Evaluation using a structured parental satisfaction questionnaire

    Time frame: 1, 3, 6, 9 and 12 months

07

Study locations

1 site
  • Faculty of Dentistry, MSA University
    Giza, Giza Governorate 12611, Egypt
    • Khaled Abdelmonem, Master degree · Contact · kasayed@msa.edu.eg · 01114537612
    • khaled Abdelmonem, master degree · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07382245
Lead sponsor
October University for Modern Sciences and Arts
Responsible party
khaled sayed (lecturer assistant at pediatric dentistry department- faculty of dentistry- October University for Modern Sciences and Arts -, October University for Modern Sciences and Arts) — Principal investigator
First posted
Feb 2, 2026
Start date
Jan 30, 2026 (estimated)
Primary completion
Feb 25, 2026 (estimated)
Completion
Mar 15, 2026 (estimated)
Last update
Feb 2, 2026

Study contacts

Khaled Abdelmonem Sayed Assistant Lecturer at Pediatric Dentistry Department, Master Holder
Contact
kasayed@msa.edu.eg
+201114537612

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion